ICMR recommends use of hydroxy-chloroquine for Covid-19 treatment

The India Council of Medical Research (ICMR), a medical research institute in India, has recommended the use of hydroxy-chloroquine for prophylaxis of SARS-CoV-2 infection.

ICMR disclosed the recommendation on its website on Monday, saying that hydroxy- chloroquine was found to be effective against coronavirus in laboratory studies and in-vivo studies.

The recommendation comes at a moment when the region is said to be the next epicenter after Europe and scientists around the world are making their highest efforts in trying to discover a vaccine or medicine for treatment of Covid-19.

Meanwhile, as Covid-19 is a disease causing respiratory infections, many scientific trials are on to facilitate the development of treatments with the medicines, which are already available in the market for treatment of other diseases.

According to ICMR, hydroxy-chloroquine could be used for asymptomatic healthcare workers involved in the care of suspected or confirmed cases of COVID-19 and asymptomatic household contacts of laboratory confirmed cases.

They however, said the medicine would not be recommended for children aged under 15 and contraindicated in persons with known cases of retinopathy, known hypersensitivity to hydroxychloroquine, 4-aminoquinoline compounds.

Although the ICMR has made the announcement, the global community is yet to accept it as a treatment. The Centre for Disease Control and Prevention (CDC) in the US is yet to approve it before it can be prescribed by physicians as treatment of Covid-19.

According to the New York Times, scientists have identified 69 drugs to test against the coronavirus. Among them, two dozen drugs, including chloroquine, are already under investigation.    

Quoting a recent study, the report mentioned that the scientists had investigated 26 of the coronavirus’s 29 genes. The researchers found 332 human proteins targeted by the coronavirus.

New York moved to begin trials Tuesday, procuring 70,000 doses of hydroxychloroquine and 750,000 doses of chloroquine, CNN reports.

However, CDC has advised that doctors should be cautious when giving the drug to patients with chronic diseases, such as kidney failure, and especially those who are receiving medications that might interact to cause arrhythmias.

In a recent development, Jordan has become one of the first countries to use the antimalarial drug hydroxychloroquine in treating patients with Covid-19. The treatment began on March 23.